Molecular Signatures Are Redefining Cancer Treatment
New studies demonstrate that treating cancer based on its molecular vulnerabilities, rather than where it originated, could translate to better outcomes for patients
medicine
Meet the Startups: Xpert AI Seeks Impact Through Augmented Vision
Xpert’s AI-enhanced technology shows promise in areas ranging from health care, where epilepsy diagnosis and treatment is one focus, to banking, where fraud detection is on the docket.
Most Genome Data Comes from White Folks. Scientists Are Trying to Fix That.
With a new genome sequence, more diverse data sets, and population-specific projects, scientists are making progress in representing humanity’s real DNA diversity.
Doctors Finally Care About Your Home DNA Results
After years of dismissing direct-to-consumer genetic tests, some healthcare professionals are now seeking guidelines for how to incorporate this data into patient care.
A Promising Vaccine Candidate for the Immunocompromised
Millions of people with weakened immune systems are poorly protected against Covid by current vaccines. Scientists in Germany have developed a new vaccine intended especially for them.
36 People Willingly Got Covid: What Scientists Learned
A bunch of healthy but brave people signed up to get infected with Covid and be studied closely. We learned, among other things, that the virus is transmissible sooner than expected, and that patients continue...
After Covid: Diabetes, Brain Damage, Stroke
More and more studies are showing that even mild Covid cases can lead to increased risk of severe health issues long after the initial infection is over.
Improving Drug Development with AI, Not Animals
Tremendous resources are wasted on would-be treatments that never even make it to the clinical trial stage because, often, tests conducted on animals provided misleading results. Dr. Jo Varshney is out to fix that.
A Breakthrough Cancer Therapy Targets Autoimmune Diseases
CAR T therapies juice the immune system. In cancer, they have cured patients who had little hope for survival. Now scientists are asking "What else can they do?"
